APO Research

APO RESEARCH · REPORT

Lacidipine Tablets

Selected research

Industry Growth & Trends

Global Lacidipine Tablets Industry Growth and Trends Forecast to 2032

Market perspective

The global Lacidipine Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lacidipine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lacidipine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lacidipine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lacidipine Tablets include GSK, Harbin Pharmaceutical Group, Teva Pharmaceuticals, Dr Reddy's Laboratories and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lacidipine Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lacidipine Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lacidipine Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lacidipine Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lacidipine Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lacidipine Tablets Market by Company

GSK

Harbin Pharmaceutical Group

Teva Pharmaceuticals

Dr Reddy's Laboratories

Boehringer Ingelheim

Lacidipine Tablets Segment by Type

2mg

4mg

Lacidipine Tablets Segment by Application

Hospital and Clinic

Pharmacy

Lacidipine Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lacidipine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lacidipine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lacidipine Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lacidipine Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lacidipine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 2mg Table 2. Major Company of 4mg Table 3. Global Lacidipine Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Lacidipine Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Lacidipine Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Lacidipine Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Lacidipine Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Lacidipine Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Lacidipine Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Lacidipine Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Lacidipine Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Lacidipine Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Lacidipine Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Lacidipine Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Lacidipine Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Lacidipine Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Lacidipine Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Lacidipine Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Lacidipine Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Lacidipine Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Lacidipine Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Lacidipine Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Lacidipine Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Lacidipine Tablets Industry Trends Table 25. Lacidipine Tablets Industry Drivers Table 26. Lacidipine Tablets Industry Opportunities and Challenges Table 27. Lacidipine Tablets Industry Restraints Table 28. Global Lacidipine Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Lacidipine Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Lacidipine Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Lacidipine Tablets Sales Share by Company (2021-2026) Table 32. Global Lacidipine Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Lacidipine Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Lacidipine Tablets Major Company Production Sites and Headquarters Table 35. Global Lacidipine Tablets Company, Product Type & Application Table 36. Global Lacidipine Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Lacidipine Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Lacidipine Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Lacidipine Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Lacidipine Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Lacidipine Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Lacidipine Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Lacidipine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Lacidipine Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Lacidipine Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Lacidipine Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Lacidipine Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Lacidipine Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Lacidipine Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Lacidipine Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Lacidipine Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Lacidipine Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Lacidipine Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Lacidipine Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Lacidipine Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Lacidipine Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Lacidipine Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Lacidipine Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Lacidipine Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Lacidipine Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Lacidipine Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Lacidipine Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Lacidipine Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Lacidipine Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Lacidipine Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Lacidipine Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Lacidipine Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Lacidipine Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Lacidipine Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. GSK Company Information Table 72. GSK Business Overview Table 73. GSK Lacidipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. GSK Lacidipine Tablets Product Portfolio Table 75. GSK Recent Development Table 76. Harbin Pharmaceutical Group Company Information Table 77. Harbin Pharmaceutical Group Business Overview Table 78. Harbin Pharmaceutical Group Lacidipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Harbin Pharmaceutical Group Lacidipine Tablets Product Portfolio Table 80. Harbin Pharmaceutical Group Recent Development Table 81. Teva Pharmaceuticals Company Information Table 82. Teva Pharmaceuticals Business Overview Table 83. Teva Pharmaceuticals Lacidipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Teva Pharmaceuticals Lacidipine Tablets Product Portfolio Table 85. Teva Pharmaceuticals Recent Development Table 86. Dr Reddy's Laboratories Company Information Table 87. Dr Reddy's Laboratories Business Overview Table 88. Dr Reddy's Laboratories Lacidipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Dr Reddy's Laboratories Lacidipine Tablets Product Portfolio Table 90. Dr Reddy's Laboratories Recent Development Table 91. Boehringer Ingelheim Company Information Table 92. Boehringer Ingelheim Business Overview Table 93. Boehringer Ingelheim Lacidipine Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Boehringer Ingelheim Lacidipine Tablets Product Portfolio Table 95. Boehringer Ingelheim Recent Development Table 96. North America Lacidipine Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. North America Lacidipine Tablets Sales by Country (2021-2026) & (K Units) Table 98. North America Lacidipine Tablets Sales Market Share by Country (2021-2026) Table 99. North America Lacidipine Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 100. North America Lacidipine Tablets Sales Market Share Forecast by Country (2027-2032) Table 101. North America Lacidipine Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Lacidipine Tablets Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Lacidipine Tablets Market Share by Country (2021-2026) Table 104. North America Lacidipine Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Lacidipine Tablets Market Share Forecast by Country (2027-2032) Table 106. Europe Lacidipine Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Europe Lacidipine Tablets Sales by Country (2021-2026) & (K Units) Table 108. Europe Lacidipine Tablets Sales Market Share by Country (2021-2026) Table 109. Europe Lacidipine Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 110. Europe Lacidipine Tablets Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Lacidipine Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Lacidipine Tablets Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Lacidipine Tablets Market Share by Country (2021-2026) Table 114. Europe Lacidipine Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Lacidipine Tablets Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Lacidipine Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Lacidipine Tablets Sales by Country (2021-2026) & (K Units) Table 118. Asia-Pacific Lacidipine Tablets Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Lacidipine Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 120. Asia-Pacific Lacidipine Tablets Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Lacidipine Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Lacidipine Tablets Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Lacidipine Tablets Market Share by Country (2021-2026) Table 124. Asia-Pacific Lacidipine Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Lacidipine Tablets Market Share Forecast by Country (2027-2032) Table 126. Latin America Lacidipine Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Latin America Lacidipine Tablets Sales by Country (2021-2026) & (K Units) Table 128. Latin America Lacidipine Tablets Sales Market Share by Country (2021-2026) Table 129. Latin America Lacidipine Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 130. Latin America Lacidipine Tablets Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Lacidipine Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Lacidipine Tablets Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Lacidipine Tablets Market Share by Country (2021-2026) Table 134. Latin America Lacidipine Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Lacidipine Tablets Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Lacidipine Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Lacidipine Tablets Sales by Country (2021-2026) & (K Units) Table 138. Middle East and Africa Lacidipine Tablets Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Lacidipine Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Lacidipine Tablets Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Lacidipine Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Lacidipine Tablets Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Lacidipine Tablets Market Share by Country (2021-2026) Table 144. Middle East and Africa Lacidipine Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Lacidipine Tablets Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Lacidipine Tablets Distributors List Table 149. Lacidipine Tablets Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Lacidipine Tablets Image Figure 2. Global Lacidipine Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lacidipine Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Lacidipine Tablets Sales (2021-2032) & (K Units) Figure 5. 2mg Image Figure 6. Global 2mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 4mg Image Figure 8. Global 4mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Lacidipine Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Lacidipine Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Lacidipine Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Lacidipine Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Lacidipine Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Lacidipine Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Lacidipine Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Lacidipine Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Lacidipine Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Lacidipine Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Lacidipine Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Lacidipine Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Lacidipine Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Lacidipine Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Lacidipine Tablets Market Share by Application 2025 VS 2032 Figure 29. North America Lacidipine Tablets Sales Market Share in Volume by Application in 2025 Figure 30. North America Lacidipine Tablets Sales Market Share in Value by Application in 2025 Figure 31. Europe Lacidipine Tablets Sales Market Share in Volume by Application in 2025 Figure 32. Europe Lacidipine Tablets Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Lacidipine Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Lacidipine Tablets Sales Market Share in Value by Application in 2025 Figure 35. Latin America Lacidipine Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Lacidipine Tablets Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Lacidipine Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Lacidipine Tablets Sales Market Share in Value by Application in 2025 Figure 39. North America Lacidipine Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Lacidipine Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Lacidipine Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Lacidipine Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Lacidipine Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Lacidipine Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Lacidipine Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Lacidipine Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Lacidipine Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Lacidipine Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Lacidipine Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Lacidipine Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Lacidipine Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Lacidipine Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Lacidipine Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Lacidipine Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Lacidipine Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Lacidipine Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Lacidipine Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Lacidipine Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Lacidipine Tablets Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Lacidipine Tablets Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 2mg
  • 4mg
Applications
  • Hospital and Clinic
  • Pharmacy
Companies covered
  • GSK
  • Harbin Pharmaceutical Group
  • Teva Pharmaceuticals
  • Dr Reddy's Laboratories
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lacidipine Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lacidipine Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lacidipine Tablets Market by Type
  6. 1.3.1 2mg
  7. 1.3.2 4mg
  8. 1.4 Global Lacidipine Tablets Market Size by Type
  9. 1.4.1 Global Lacidipine Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Lacidipine Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Lacidipine Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Lacidipine Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Lacidipine Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Lacidipine Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Lacidipine Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Lacidipine Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lacidipine Tablets Industry Trends
  2. 2.2 Lacidipine Tablets Industry Drivers
  3. 2.3 Lacidipine Tablets Industry Opportunities and Challenges
  4. 2.4 Lacidipine Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lacidipine Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Lacidipine Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Lacidipine Tablets Price (2021-2026)
  4. 3.4 Global Lacidipine Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lacidipine Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Lacidipine Tablets Company, Product Type & Application
  7. 3.7 Global Lacidipine Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lacidipine Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lacidipine Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lacidipine Tablets Tier 1, Tier 2, and Tier 3
4 Lacidipine Tablets Regional Status and Outlook
  1. 4.1 Global Lacidipine Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lacidipine Tablets Historic Market Size by Region
  3. 4.2.1 Global Lacidipine Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lacidipine Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lacidipine Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lacidipine Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Lacidipine Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lacidipine Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lacidipine Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lacidipine Tablets by Application
  1. 5.1 Lacidipine Tablets Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.2 Global Lacidipine Tablets Market Size by Application
  5. 5.2.1 Global Lacidipine Tablets Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Lacidipine Tablets Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Lacidipine Tablets Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Lacidipine Tablets Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Lacidipine Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Lacidipine Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Lacidipine Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Lacidipine Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Lacidipine Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Lacidipine Tablets Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Harbin Pharmaceutical Group
  8. 6.2.1 Harbin Pharmaceutical Group Company Information
  9. 6.2.2 Harbin Pharmaceutical Group Business Overview
  10. 6.2.3 Harbin Pharmaceutical Group Lacidipine Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Harbin Pharmaceutical Group Lacidipine Tablets Product Portfolio
  12. 6.2.5 Harbin Pharmaceutical Group Recent Developments
  13. 6.3 Teva Pharmaceuticals
  14. 6.3.1 Teva Pharmaceuticals Company Information
  15. 6.3.2 Teva Pharmaceuticals Business Overview
  16. 6.3.3 Teva Pharmaceuticals Lacidipine Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Teva Pharmaceuticals Lacidipine Tablets Product Portfolio
  18. 6.3.5 Teva Pharmaceuticals Recent Developments
  19. 6.4 Dr Reddy's Laboratories
  20. 6.4.1 Dr Reddy's Laboratories Company Information
  21. 6.4.2 Dr Reddy's Laboratories Business Overview
  22. 6.4.3 Dr Reddy's Laboratories Lacidipine Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Dr Reddy's Laboratories Lacidipine Tablets Product Portfolio
  24. 6.4.5 Dr Reddy's Laboratories Recent Developments
  25. 6.5 Boehringer Ingelheim
  26. 6.5.1 Boehringer Ingelheim Company Information
  27. 6.5.2 Boehringer Ingelheim Business Overview
  28. 6.5.3 Boehringer Ingelheim Lacidipine Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Boehringer Ingelheim Lacidipine Tablets Product Portfolio
  30. 6.5.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Lacidipine Tablets Sales by Country
  2. 7.1.1 North America Lacidipine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lacidipine Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Lacidipine Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lacidipine Tablets Market Size by Country
  6. 7.2.1 North America Lacidipine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lacidipine Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Lacidipine Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lacidipine Tablets Sales by Country
  2. 8.1.1 Europe Lacidipine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lacidipine Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Lacidipine Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lacidipine Tablets Market Size by Country
  6. 8.2.1 Europe Lacidipine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lacidipine Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lacidipine Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lacidipine Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Lacidipine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lacidipine Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lacidipine Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lacidipine Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Lacidipine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lacidipine Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lacidipine Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lacidipine Tablets Sales by Country
  2. 10.1.1 South America Lacidipine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lacidipine Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Lacidipine Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lacidipine Tablets Market Size by Country
  6. 10.2.1 South America Lacidipine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lacidipine Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Lacidipine Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lacidipine Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Lacidipine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lacidipine Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lacidipine Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lacidipine Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Lacidipine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lacidipine Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lacidipine Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lacidipine Tablets Value Chain Analysis
  2. 12.1.1 Lacidipine Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lacidipine Tablets Production Mode & Process
  7. 12.2 Lacidipine Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lacidipine Tablets Distributors
  10. 12.2.3 Lacidipine Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research